| 25 May 2026 |
BPC-157 Arg Oral |
7.5 |
10mg |
10.4mg |
+4.2% |
97.76% |
Lab F |
| 25 May 2026 |
Clomid |
7.5 |
25mg |
28.6mg |
+14.2% |
99.91% |
Lab F |
| 25 May 2026 |
Livagen |
6.6 |
30mg |
33.7mg |
+12.4% |
97.39% |
Lab G |
| 25 May 2026 |
Minoxidil Oral |
5.6 |
25mg |
21.6mg |
-13.4% |
97.66% |
Lab G |
| 25 May 2026 |
SLU-PP-332 |
9.9 |
25mg |
31.2mg |
+24.8% |
96.31% |
Lab F |
| 24 May 2026 |
Anastrozole (Arimidex) Raw |
7.9 |
100g |
85.8g |
-14.2% |
95.82% |
Lab C |
| 24 May 2026 |
Glutathione |
9.6 |
5mg |
5.4mg |
+7.5% |
98.78% |
Lab C |
| 24 May 2026 |
Selank 10mg + Semax 10mg Blend |
5.2 |
50mg |
60.5mg |
+21.1% |
96.01% |
Lab F |
| 24 May 2026 |
SLU-PP-332 |
10.0 |
100mg |
87.0mg |
-13.0% |
98.20% |
Lab E |
| 24 May 2026 |
Minoxidil Oral |
6.7 |
20mg |
20.4mg |
+2.0% |
96.87% |
Lab D |
| 24 May 2026 |
Trestolone Acetate (MENT) Raw |
5.8 |
5g |
5.0g |
-0.2% |
96.98% |
Lab D |
| 24 May 2026 |
T3 (Liothyronine) |
6.9 |
100mg |
95.3mg |
-4.7% |
99.26% |
Lab B |
| 24 May 2026 |
Trestolone Acetate (MENT) Raw |
8.3 |
5g |
5.9g |
+18.4% |
99.46% |
Lab C |
| 24 May 2026 |
Methylamine (base) CAS 74-89-5 |
6.3 |
5g |
4.5g |
-9.8% |
97.98% |
Lab F |
| 24 May 2026 |
Retatrutide |
7.8 |
30mg |
30.7mg |
+2.3% |
99.80% |
Lab G |
| 24 May 2026 |
Retatrutide |
7.8 |
30mg |
29.4mg |
-2.0% |
99.80% |
Lab G |
| 24 May 2026 |
AICAR |
6.5 |
2mg |
2.4mg |
+21.9% |
95.12% |
Lab E |
| 24 May 2026 |
DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 |
7.6 |
10g |
10.1g |
+1.1% |
99.95% |
Lab B |
| 24 May 2026 |
Semax |
6.7 |
50mg |
57.8mg |
+15.5% |
96.04% |
Lab E |
| 24 May 2026 |
T3 (Liothyronine) |
5.2 |
50mg |
61.1mg |
+22.3% |
98.15% |
Lab E |
| 23 May 2026 |
Tirzepatide |
6.8 |
30mg |
31.6mg |
+5.3% |
94.16% |
Lab E |
| 23 May 2026 |
Retatrutide |
8.0 |
20mg |
19.5mg |
-2.5% |
99.90% |
Lab E |
| 23 May 2026 |
Retatrutide |
7.8 |
20mg |
17.3mg |
-13.5% |
99.90% |
Lab E |
| 23 May 2026 |
Tirzepatide |
9.8 |
60mg |
60mg |
|
99.80% |
Lab E |
| 23 May 2026 |
Finasteride |
6.6 |
50mg |
45.7mg |
-8.7% |
96.13% |
Lab E |
| 23 May 2026 |
Letrozole |
8.2 |
10mg |
12.0mg |
+20.4% |
97.96% |
Lab A |
| 23 May 2026 |
Ostarine (MK-2866) |
7.5 |
100mg |
105.4mg |
+5.4% |
98.70% |
Lab B |
| 23 May 2026 |
Nitroethane CAS 79-24-3 |
6.6 |
500g |
534.6g |
+6.9% |
96.55% |
Lab B |
| 21 May 2026 |
Retatrutide |
7.8 |
30mg |
30mg |
|
99.80% |
Lab G |
| 21 May 2026 |
Selank 10mg + Semax 10mg Blend |
6.5 |
20mg |
23.7mg |
+18.6% |
96.16% |
Lab G |
| 21 May 2026 |
Clomid |
6.4 |
50mg |
54.2mg |
+8.4% |
96.20% |
Lab G |
| 21 May 2026 |
Methylamine (base) CAS 74-89-5 |
7.6 |
500g |
489.4g |
-2.1% |
97.38% |
Lab A |
| 21 May 2026 |
MOTS-C |
4.4 |
50mg |
52.1mg |
+4.2% |
98.84% |
Lab F |
| 20 May 2026 |
DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 |
8.4 |
1g |
0.9g |
-8.7% |
95.21% |
Lab F |
| 20 May 2026 |
Ivermectin |
7.1 |
20mg |
24.9mg |
+24.5% |
96.76% |
Lab C |
| 19 May 2026 |
DNP |
8.2 |
50mg |
43.9mg |
-12.2% |
95.14% |
Lab B |
| 19 May 2026 |
MOTS-C |
4.1 |
5mg |
5.4mg |
+8.6% |
95.26% |
Lab F |
| 19 May 2026 |
NAD+ |
8.6 |
5mg |
5.0mg |
-0.9% |
96.40% |
Lab G |
| 17 May 2026 |
Anastrozole (Arimidex) Raw |
7.5 |
500g |
551.3g |
+10.3% |
95.05% |
Lab G |
| 17 May 2026 |
Livagen |
7.5 |
30mg |
32.6mg |
+8.8% |
95.75% |
Lab A |
| 17 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
5.5 |
200mg/ml |
208.9mg/ml |
+4.5% |
99.94% |
Lab F |
| 29 Jan 2026 |
Clomid |
7.2 |
10mg |
10.1mg |
+1.5% |
97.55% |
Lab B |
| 29 Jan 2026 |
DSIP |
6.4 |
5mg |
4.7mg |
-6.9% |
98.15% |
Lab A |
| 29 Jan 2026 |
Epithalon |
7.3 |
5mg |
4.7mg |
-6.4% |
97.78% |
Lab E |
| 26 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.8 |
10mg |
9.0mg |
-10.3% |
97.67% |
Lab D |
| 26 Jan 2026 |
Crystagen |
4.0 |
15mg |
18.1mg |
+20.9% |
98.90% |
Lab B |
| 26 Jan 2026 |
DNP |
9.0 |
20mg |
24.8mg |
+24.1% |
96.73% |
Lab C |
| 26 Jan 2026 |
Retatrutide 30mg Pen Kit |
6.9 |
30mg |
32.9mg |
+9.6% |
95.11% |
Lab D |
| 19 Jan 2026 |
IGF-1 LR3 |
6.2 |
30mg |
32.6mg |
+8.5% |
98.15% |
Lab A |
| 19 Jan 2026 |
Letrozole |
10.0 |
50mg |
45.3mg |
-9.4% |
96.66% |
Lab C |
| 19 Jan 2026 |
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 |
4.0 |
1g |
1.1g |
+9.2% |
97.32% |
Lab D |
| 9 Jan 2026 |
BPC-157 Arg Oral |
6.1 |
10mg |
10.8mg |
+7.6% |
96.72% |
Lab D |
| 9 Jan 2026 |
HGH 191AA (Somatropin) |
7.9 |
15mg |
15.4mg |
+2.5% |
99.30% |
Lab G |
| 9 Jan 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.8 |
50mg |
50.4mg |
+0.7% |
95.62% |
Lab B |
| 9 Jan 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
5.8 |
30mg |
26.1mg |
-13.1% |
95.64% |
Lab C |
| 7 Jan 2026 |
HGH 191AA (Somatropin) |
8.0 |
50mg |
59.4mg |
+18.7% |
95.32% |
Lab D |
| 6 Jan 2026 |
Finasteride |
6.3 |
10mg |
9.6mg |
-3.9% |
99.06% |
Lab G |
| 6 Jan 2026 |
Superdrol |
8.5 |
25mg |
22.8mg |
-8.9% |
95.98% |
Lab G |
| 6 Jan 2026 |
Vilon |
7.6 |
2mg |
1.9mg |
-2.9% |
97.40% |
Lab C |
| 29 Dec 2025 |
DSIP |
7.1 |
2mg |
2.4mg |
+18.5% |
97.22% |
Lab G |
| 29 Dec 2025 |
SNAP-8 |
8.2 |
10mg |
9.3mg |
-6.6% |
99.46% |
Lab G |
| 12 Dec 2025 |
Letrozole |
7.5 |
100mg |
104.7mg |
+4.7% |
97.22% |
Lab D |
| 12 Dec 2025 |
Livagen |
5.1 |
10mg |
9.1mg |
-9.1% |
98.14% |
Lab B |
| 12 Dec 2025 |
SR9009 |
9.0 |
10mg |
11.7mg |
+16.6% |
98.01% |
Lab A |
| 5 Dec 2025 |
Anastrozole (Arimidex) Raw |
8.3 |
500g |
475.4g |
-4.9% |
96.01% |
Lab B |
| 5 Dec 2025 |
Crystagen |
7.3 |
20mg |
24.0mg |
+19.8% |
97.29% |
Lab G |
| 5 Dec 2025 |
IGF-1 LR3 |
7.1 |
50mg |
55.9mg |
+11.7% |
98.55% |
Lab F |
| 5 Dec 2025 |
Methylamine (base) CAS 74-89-5 |
7.4 |
100g |
93.3g |
-6.7% |
96.41% |
Lab F |
| 5 Dec 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.2 |
30mg |
26.2mg |
-12.7% |
95.87% |
Lab F |
| 23 Nov 2025 |
AA Water |
7.2 |
10mg |
12.1mg |
+21.2% |
98.25% |
Lab F |
| 17 Nov 2025 |
DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 |
7.8 |
10g |
9.9g |
-1.3% |
99.79% |
Lab F |
| 17 Nov 2025 |
FOXO4 |
6.2 |
50mg |
42.5mg |
-15.0% |
99.83% |
Lab G |
| 14 Nov 2025 |
AA Water |
5.0 |
10mg |
12.2mg |
+22.2% |
97.69% |
Lab C |
| 14 Nov 2025 |
SNAP-8 |
7.9 |
50mg |
51.5mg |
+2.9% |
95.35% |
Lab A |
| 5 Nov 2025 |
BPC-157 Arg Oral |
4.0 |
25mg |
23.7mg |
-5.1% |
97.21% |
Lab F |
| 5 Nov 2025 |
Retatrutide 30mg Pen Kit |
7.7 |
20mg |
17.5mg |
-12.6% |
95.53% |
Lab E |
| 5 Nov 2025 |
Trestolone Acetate (MENT) Raw |
8.4 |
5g |
6.2g |
+24.2% |
97.95% |
Lab C |
| 4 Nov 2025 |
Crystagen |
5.1 |
15mg |
15.1mg |
+0.9% |
96.75% |
Lab G |
| 17 Oct 2025 |
HGH 191AA (Somatropin) |
6.3 |
10mg |
8.9mg |
-10.6% |
98.85% |
Lab A |
| 17 Oct 2025 |
SR9009 |
8.5 |
10mg |
10.2mg |
+1.5% |
95.19% |
Lab D |
| 17 Oct 2025 |
SR9009 |
7.9 |
50mg |
51.3mg |
+2.6% |
97.24% |
Lab D |
| 9 Oct 2025 |
Chonluten |
7.5 |
20mg |
19.1mg |
-4.3% |
98.28% |
Lab F |
| 9 Oct 2025 |
SLU-PP-332 |
6.4 |
50mg |
51.8mg |
+3.5% |
99.52% |
Lab D |
| 3 Oct 2025 |
Retatrutide 30mg Pen Kit |
5.5 |
10mg |
11.3mg |
+12.8% |
95.86% |
Lab D |
| 3 Oct 2025 |
Semax |
9.7 |
2mg |
2.5mg |
+23.2% |
97.04% |
Lab C |